Pharmabiz

US FDA grants fast track designation to Sanofi’s AAV gene therapy, SAR446268 to treat non-congenital myotonic dystrophy type 1

US FDA grants fast track designation to Sanofi’s AAV gene therapy, SAR446268 to treat non-congenital myotonic dystrophy type 1: Paris Wednesday, September 24, 2025, 09:00 Hrs [I ...
Pharmabiz

NCISM grants permission to 20 new Ayurveda Medical Colleges in AY 2025-26

The National Commission for Indian System of Medicine (NCISM) has granted Letter of Permission to 20 entities to establish ...
Pharmabiz

PCI introduces dedicated elective on cGMP in new B Pharm syllabus

PCI introduces dedicated elective on cGMP in new B Pharm syllabus: Nandita Vijayasimha, Bengaluru Wednesday, September 24, 2025, 08:00 Hrs [IST] The Pharmacy Council of India (PCI ...
Pharmabiz

DCA Telangana detects major violations in 115 corporate hospital pharmacies

DCA Telangana detects major violations in 115 corporate hospital pharmacies: Peethaambaran Kunnathoor, Chennai Wednesday, September 24, 2025, 08:00 Hrs [IST] The Drugs Control Adm ...
Pharmabiz

Pharma exports register 7 per cent growth in August

Exports of drugs and pharmaceuticals from the country registered around 7 per cent growth in the month of August, while imports reported an increase of around 1.26 per cent compared to the same month ...
Pharmabiz

India reschedules hearing in anti-dumping probe on import of methyl acetoacetate from China

India reschedules hearing in anti-dumping probe on import of methyl acetoacetate from China: Shardul Nautiyal, Mumbai Wednesday, September 24, 2025, 08:00 Hrs [IST] The Directorat ...
Opinion
PharmabizOpinion

A GST RELIEF FOR PATIENTS

Ramesh Shankar Wednesday, September 24, 2025, 08:00 Hrs [IST] The 56th meeting of the GST Council led by Union Finance Minister Nirmala Sitaraman has re ...
Pharmabiz

India's missed shot, world is winning race for cancer cures

Dr. Rahul Maheshwari Wednesday, September 24, 2025, 08:00 Hrs [IST] Cancer has become one of the greatest threats to g ...
Pharmabiz

BlueRock announces first Parkinson’s disease patient treated in pivotal phase III trial of investigational cell therapy bemdaneprocel

Cambridge, Massachusetts Tuesday, September 23, 2025, 18:00 Hrs [IST] ...
Pharmabiz

NIMHANS launches AYUSH-MANN to create awareness on integrative approaches to treat mental-neuro disorders

NIMHANS launches AYUSH-MANN to create awareness on integrative approaches to treat mental-neuro disorders: Our Bureau, Bengaluru Tuesday, September 23, 2025, 17:15 Hrs [IST] Natio ...
Pharmabiz

AstraZeneca announces EMA committee recommends approval of Koselugo to treat plexiform neurofibromas in adults with neurofibromatosis type 1

AstraZeneca announces EMA committee recommends approval of Koselugo to treat plexiform neurofibromas in adults with neurofibromatosis type 1: Cambridge, UK Tuesday, September 23, ...
Pharmabiz

US FDA extends target action date to review Sanofi’s NDA for tolebrutinib in non-relapsing, secondary progressive multiple sclerosis

US FDA extends target action date to review Sanofi’s NDA for tolebrutinib in non-relapsing, secondary progressive multiple sclerosis: Paris Tuesday, September 23, 2025, 16:00 Hr ...